Anika Therapeutics Inc. | Ownership

Companies that own Anika Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
1,936,631
13.28%
132,514
0%
06/30/2018
Kayne Anderson Rudnick Investment Management LLC
1,600,173
10.97%
-107,152
0.37%
06/30/2018
Dimensional Fund Advisors LP
977,569
6.7%
46,798
0.01%
06/30/2018
The Vanguard Group, Inc.
838,747
5.75%
28,124
0%
06/30/2018
First Manhattan Co.
492,602
3.38%
453,902
0.11%
06/30/2018
SSgA Funds Management, Inc.
488,562
3.35%
85,183
0%
06/30/2018
Morgan Stanley & Co. LLC
478,058
3.28%
446,330
0.02%
06/30/2018
Wellington Management Co. LLP
382,998
2.63%
-666,095
0%
06/30/2018
AMI Asset Management Corp.
344,668
2.36%
98,873
0.93%
06/30/2018
Renaissance Technologies LLC
317,500
2.18%
115,400
0.01%
06/30/2018

About Anika Therapeutics

View Profile
Address
32 Wiggins Avenue
Bedford Massachusetts 01730
United States
Employees -
Website http://www.anikatherapeutics.com
Updated 07/08/2019
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary.